PSI CRO

Zug, Switzerland Founded: 1995 • Age: 31 yrs
Global contract research organization managing clinical trials in various therapeutic areas.

About PSI CRO

PSI CRO is a Healthcare company based in Zug (Switzerland) founded in 1995. Global contract research organization managing clinical trials in various therapeutic areas. It operates on a B2B model. Its website psi-cro.com draws about 681 thousand monthly visits. Its Indian entity Psi Cro Pharma India Private Limited reported revenue of ₹4.62 Cr. PSI CRO offers products and services including VISIONAL™ and INTELIA™. Its focus areas include Biotech and Pharma, Clinical Trials, Rare Diseases Research and Oncology Development.

Company details

PSI CRO is a global contract research organization that specializes in managing Phase 2 and 3 clinical trials for pharmaceutical companies, ensuring they run on time and within budget. Based in Zug, Switzerland, they offer expertise in therapeutic areas such as oncology, inflammatory bowel diseases, hematology, infectious diseases, multiple sclerosis, and rare diseases. They utilize advanced tools like VISIONAL for trial planning and provide comprehensive services including protocol development, enrollment predictions, and site collaboration to support drug development.

  • Headquarters Zug, Switzerland
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website psi-cro.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Psi Cro Pharma India Private Limited
  • Date of Incorporation 05 Sep, 2008
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Indian entity revenue
    ₹4.62 Cr

    FY 2020 · +20% YoY

  • Indian entity net profit
    ₹3.3 Lakh

    FY 2020 · 1% margin

  • Indian entity EBITDA
    ₹10.6 Lakh

    FY 2020 · 2% margin

Products & Services of PSI CRO

PSI CRO offers a comprehensive portfolio of products and services, including VISIONAL™ and INTELIA™.

VISIONAL™
Trial Planning Tool

AI-powered platform for protocol search and enrollment predictions in trials.

INTELIA™
Therapeutic Management Service

Tool for global reach in clinical research and event management.

Apps and channels of PSI CRO

its YouTube channel PSI CRO has 125 subscribers and 30 videos.

PSI CRO
YouTube 125 subscribers 30 videos Science & Technology
Open channel

Videos from PSI CRO

The most watched videos on PSI CRO's YouTube channel, PSI CRO (125 subscribers). Click a video to play it here.

Week in Review; Jan 2
494 views
PSI CRO and Gift of Life Marrow Registry at ASCO 2018
252 views
PSI CRO New Booth at ASCO 2018 - Gift of Life Marrow Registry
193 views
Clinical Trials Day 2018
152 views

More on PSI CRO.

Board of directors of Psi Cro Pharma India Private Limited (PSI CRO)

Psi Cro Pharma India Private Limited is the primary company behind PSI CRO. The board of Psi Cro Pharma India Private Limited currently have 4 directors; the longest-serving is Nikolay Sinakevich, appointed in 2008. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Nikolay Sinakevich
DIN 02388029
Director23 Dec 200817 yrs 10 moPsi Cro Pharma India Private Limited
Srikanth Narasimhan
DIN 01848872
Director30 Jun 201511 yrs 4 moPsi Cro Pharma India Private Limited
Albertine Varone
DIN 09123407
Director19 Apr 20215 yrs 6 moPsi Cro Pharma India Private Limited
Andrey Kozhemyakin
DIN 09122880
Director19 Apr 20215 yrs 6 moPsi Cro Pharma India Private Limited

Financials of PSI CRO

Figures of Psi Cro Pharma India Private Limited, the primary company behind PSI CRO, for FY 2020. Revenue was ₹4.62 Cr (+20% year on year). Net profit was ₹3.3 Lakh (1% margin). EBITDA was ₹10.6 Lakh (2% margin). Revenue has grown at a compounded annual rate of +84% over three years and +52% over five years.

  • ₹4.62 CrRevenue · FY 2020 · +20% YoY
  • ₹3.3 LakhNet profit · 1% margin
  • ₹10.6 LakhEBITDA · 2% margin
  • ₹10 LakhPaid-up capital
  • 21Employees (provident fund records)
  • +84%Revenue CAGR, 3 years
  • +52%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Psi Cro Pharma India Private Limited are on its company page.

Premium access

Detailed financial statements for PSI CRO

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of PSI CRO

The website of PSI CRO (psi-cro.com) receives about 680.7K visits a month and ranks #605,800 among all websites worldwide, #644 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    680.7K

    ▼ 6.7% vs previous month

  • Unique visitors
    20.4K

    per month

  • Global rank
    #605,800

    among all websites

  • Category rank
    #644

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with PSI CRO. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
falconebiz.com
100%
959.8K#63,970View details
tofler.in
97%
556K#105,509View details
zaubacorp.com
96%
4.9M#12,689View details
tracxn.com
92%
2.9M#16,597View details
indiafilings.com
90%
2.1M#29,959View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for PSI CRO

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Psi Cro

Premium access

Complete news archive for PSI CRO

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PSI CRO

PSI CRO was founded in 1995.

PSI CRO is headquartered in Zug, Switzerland. It is registered at Zug, Zug, Switzerland.

The primary company behind PSI CRO, Psi Cro Pharma India Private Limited, reported revenue of ₹4.62 Cr for FY 2020, up 20% year on year.

PSI CRO is a global contract research organization that specializes in managing Phase 2 and 3 clinical trials for pharmaceutical companies, ensuring they run on time and within budget. Based in Zug, Switzerland, they offer expertise in therapeutic areas such as oncology, inflammatory bowel diseases, hematology, infectious diseases, multiple sclerosis, and rare diseases. They utilize advanced tools like VISIONAL for trial planning and provide comprehensive services including protocol development, enrollment predictions, and site collaboration to support drug development.

PSI CRO offers VISIONALâ„¢ and INTELIAâ„¢.

PSI CRO operates through Psi Cro Pharma India Private Limited.

The legal entities of PSI CRO currently have 4 directors, including Nikolay Sinakevich, Albertine Varone, Andrey Kozhemyakin and others.

The website of PSI CRO receives about 681 thousand visits a month and ranks #605,800 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available